论文部分内容阅读
目的:探究肺结核患者治疗中运用复方甘草酸苷的临床成效。方法:选取平顶山市平煤神马医疗集团总医院收治的肺结核患者80例,均在2014年1月至2016年6月入院,依随机分组标准分为观察组(40例)和对照组(40例)。对照组和观察组分别给予常规基础治疗和复方甘草酸苷治疗。从临床治疗有效率、不良反应发生及生存质量状况三方面入手,针对相关内容进行分析。结果:对照组治疗总有效率(77.5%)比观察组(92.5%)低,差异具有统计学意义(P<0.05);不良反应发生情况,观察组的发生率(7.5%)与对照组的发生率(5.0%)比较,差异无统计学意义(P>0.05);在生存质量方面,观察组患者各项指标得分均比对照组高,差异具有统计学意义(P<0.05)。结论:肺结核患者治疗中运用复方甘草酸苷取得的临床成效显著,在有效提高治疗效果的同时,不良反应发生率较低,且患者生存质量显著改善。
Objective: To investigate the clinical efficacy of compound glycyrrhizin in the treatment of patients with pulmonary tuberculosis. Methods: Eighty patients with tuberculosis admitted to Pingdingshan Pingma Shenma Medical Group General Hospital were enrolled in our hospital from January 2014 to June 2016. The patients were randomly divided into observation group (40 cases) and control group (40 cases) example). Control group and observation group were given routine basic treatment and compound glycyrrhizin treatment. From the clinical treatment efficiency, the occurrence of adverse reactions and quality of life status of three aspects, for the analysis of the relevant content. Results: The total effective rate of the control group (77.5%) was lower than that of the observation group (92.5%), the difference was statistically significant (P <0.05); adverse reactions, the incidence of the observation group (7.5% (P> 0.05). The quality of life of patients in observation group was higher than that in control group (P <0.05). Conclusion: The clinical efficacy of compound glycyrrhizin in the treatment of pulmonary tuberculosis patients is remarkable. While effectively improving the therapeutic effect, the incidence of adverse reactions is low, and the quality of life of the patients is significantly improved.